Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 trends tracked about this subject — the full history, oldest to newest below.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
An FDA advisory committee has unanimously backed Moderna's mRNA-based flu vaccine, marking a significant development for the technology.
Moderna stock prices increased following positive feedback from the FDA regarding the company's mRNA influenza vaccine candidate.
Global research efforts accelerate as scientists scramble to test new vaccines and treatments in response to a widening Ebola outbreak.